ScholarIQanswers from OpenAlex

Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada

PaperCitations, authors & open-access status

Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada have?

ScholarIQcitation count

Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada has 10 citations in the OpenAlex counts ScholarIQ stores.

When was Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada published?

ScholarIQyear

Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada has 2023 year in the ScholarIQ index.

What is the open-access status of Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada?

ScholarIQoa status

Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada has hybrid oa status in the ScholarIQ index.

What is the DOI of Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada?

ScholarIQdoi

The DOI for Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada is on the source record.

What is the PMID of Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada?

ScholarIQpmid

The PMID for Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada is on the source record.

What is the OpenAlex record for Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada?

ScholarIQopenalex

The OpenAlex for Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial